Please provide your email address to receive an email when new articles are posted on . The mean successfully completed dose increased from 48 mg to 2,723 mg of peanut protein by 48 months. 70% ...

Children with peanut allergies treated with peanut oral immunotherapy for 3 years can tolerate increasingly higher exposures to peanuts. But avoidance of peanut-protein exposure for just a single ...

Oral immunotherapy (pOIT) significantly increases peanut challenge tolerance in children compared to avoidance, with 74% success in the pOIT group versus 11% in the avoidance group. The study ...

Please provide your email address to receive an email when new articles are posted on . When peanut introduction fails, peanut OIT for infants should be offered as soon as possible via shared decision ...

SAN MATEO, Calif.--Allergen Research Corporation (ARC), a privately held biopharmaceutical company developing desensitization treatments for food allergies, today announced the completion of an $80 ...